FULGENT GENETICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
FULGENT GENETICS, INC. (FLGT) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $0 as of 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2021-08-10
- 2021-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2021-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2020-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2020-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2021-06-30 | $0.00 10-Q · filed 2021-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-08 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-08 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-12 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-13 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-22 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-13 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |